Lifang Cheng Selected Research

Lifang Cheng Research Topics

Disease

13	Neoplasms (Cancer) 04/2023 - 12/2013
3	Lung Neoplasms (Lung Cancer) 10/2021 - 01/2020
3	Breast Neoplasms (Breast Cancer) 10/2021 - 12/2014
2	Inflammation (Inflammations) 03/2024 - 11/2022
2	Bullous Pemphigoid (Pemphigoid) 01/2023 - 01/2023
2	Melanoma (Melanoma, Malignant) 10/2021 - 01/2017
2	Carcinogenesis 01/2020 - 03/2017
1	Ovarian Neoplasms (Ovarian Cancer) 04/2023
1	Neoplasm Metastasis (Metastasis) 04/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023
1	Psoriatic Arthritis 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021
1	Heart Failure 01/2021
1	Osteoarthritis 10/2017
1	Colorectal Neoplasms (Colorectal Cancer) 03/2015

Drug/Important Bio-Agent (IBA)

4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 12/2014
3	Dendrimers (Dendrons)IBA 10/2020 - 12/2015
3	Folic Acid (Vitamin M)FDA LinkGeneric 12/2015 - 12/2013
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022
2	NanovaccinesIBA 10/2021 - 01/2017
2	Poly(amidoamine)IBA 01/2020 - 12/2015
2	IntegrinsIBA 01/2016 - 01/2016
2	MicellesIBA 01/2016 - 12/2014
1	GTP Phosphohydrolases (GTPases)IBA 03/2024
1	Immunoglobulin A (IgA)IBA 01/2023
1	AutoantibodiesIBA 01/2023
1	Matrix Metalloproteinases (MMPs)IBA 01/2023
1	Laminin (Merosin)IBA 01/2023
1	Docosahexaenoic AcidsIBA 11/2022
1	CytokinesIBA 11/2022
1	15-hydroxy-5,8,11,13,17-eicosapentaenoic acidIBA 11/2022
1	Eicosapentaenoic AcidIBA 11/2022
1	NanogelsIBA 01/2022
1	secukinumabIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	AntigensIBA 10/2021
1	Urea (Carbamide)FDA LinkGeneric 10/2021
1	VaccinesIBA 10/2021
1	Cancer VaccinesIBA 10/2021
1	Gefitinib (Iressa)FDA Link 10/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	PAMAM-G4IBA 10/2020
1	ClathrinIBA 01/2020
1	Transferrin (beta 2 Transferrin)IBA 01/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020
1	methoxypolyethylene glycol succinimidylsuccinateIBA 01/2020
1	PEG-PAMAMIBA 10/2017
1	Fluorescein (Funduscein)FDA LinkGeneric 10/2017
1	Long Noncoding RNAIBA 03/2017
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2017
1	CPG-oligonucleotideIBA 01/2017
1	cyclic arginine-glycine-aspartic acid peptideIBA 01/2016
1	cyclo(Arg-Gly-Asp-Tyr-Lys)IBA 01/2016
1	PAMAM StarburstIBA 12/2015
1	AcidsIBA 12/2015
1	TOR Serine-Threonine KinasesIBA 03/2015
1	polyhistidineIBA 12/2014
1	Peptides (Polypeptides)IBA 12/2014
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2014
1	Liposomes (Liposome)IBA 12/2014
1	Hyaluronic Acid (Hyaluronan)IBA 12/2014
1	polyethylene glycol 2000IBA 12/2014
1	ChitosanIBA 12/2013
1	DNA (Deoxyribonucleic Acid)IBA 12/2013
1	Proteins (Proteins, Gene)FDA Link 12/2013

Therapy/Procedure

5	Therapeutics 01/2022 - 11/2014
3	Drug Therapy (Chemotherapy) 04/2023 - 01/2016
2	Immunotherapy 01/2023 - 10/2021
1	Highly Active Antiretroviral Therapy (HAART) 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022